10X Genomics, Inc. (TXG)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about 10X Genomics, Inc. (TXG)
Go deeper and ask any question about TXG
Company Performance
Current Price
as of Sep 13, 2024$22.37
P/E Ratio
N/A
Market Cap
$2.38B
Description
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Metrics
Overview
- HQPleasanton, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerTXG
- Price$22.37-0.80%
Trading Information
- Market Cap$2.38B
- Float82.67%
- Average Daily Volume (1m)1,295,953
- Average Daily Volume (3m)1,837,298
- EPS-$2.02
Company
- Revenue$631.73M
- Rev Growth (1yr)4.28%
- Net Income-$37.90M
- Gross Margin69.82%
- EBITDA Margin-20.14%
- EBITDA-$30.84M
- EV$2.04B
- EV/Revenue3.24
- P/EN/A
- P/S4.25
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset